Surgical treatment of hepatocellular carcinoma with severe intratumoral arterioportal shunt

Table 1 Laboratory data obtained at time of hospitalization and after TAE

	At time of hospitalization	After TAE
AST level (IU/L)	86	70
ALT level (IU/L)	66	20
Total bilirubin level (mg/dL)	0.98	0.71
Albumin level (g/dL)	3.4	3.8
White blood cell count (/μL)	1800	3900
Hemoglobin level (g/dL)	9.9	9.2
Hematocrit (%)	30.7	29.8
Platelet count (/μL)	7.5 × 104	18.2 × 104
Prothrombin activity (%)	71	80
HBsAg	Negative	-
HCV Ab	Positive	-
AFP level (ng/mL)	5570	-
PIVKA-II level (mAU/mL)	5360	-
ICG-R15 (%)	36	30

TAE: Transcatheter arterial embolization; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; HBsAg: Hepatitis B surface antigen; HCV Ab: Hepatitis C virus antibody; AFP: α-fetoprotein; PIVKA-II: Protein induced by vitamin K absence or antagonist II; ICG-R15: Indocyanine green retention at 15 min after intravenous injection.